tranexamic acid + vitamin k

Tranexamic acid + vitamin K is a combination medication used to prevent and reduce bleeding. This combination works through complementary mechanisms: tranexamic acid is an antifibrinolytic agent that rapidly inhibits the breakdown of blood clots, while vitamin K promotes blood clotting through its role in the synthesis of coagulation factors, providing a delayed but sustained effect on hemostasis[2][5][6]. Clinical studies have shown that this combination is particularly effective in reducing blood loss in various surgical settings, including total hip arthroplasty, intracranial hemorrhage management, and other procedures with significant bleeding risk[2][5][6]. The combination has demonstrated superior efficacy in decreasing prothrombin time (PT) and activated partial thromboplastin time (aPTT) compared to either agent alone[5]. The administration typically involves an initial intravenous dose followed by an infusion until wound closure, allowing for bleeding control during surgery through tranexamic acid's rapid action and post-operative hemostasis through vitamin K's delayed effect[2][6][7].